708. In Vitro Activity of Plazomicin vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD study, 2011–2018

BACKGROUND: Plazomicin (PLZ) is a next-generation aminoglycoside currently approved by the US FDA for the treatment of complicated urinary tract infections, including pyelonephritis. The purpose of this study was to evaluate the in vitro activity of PLZ against a large collection of Gram-negative ba...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Walkty, Andrew, Adam, Heather, Baxter, Melanie, Lagace-Wiens, Philippe, Karlowsky, James, Zhanel, George
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.776
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items